INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹97 Cr | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr |
What is the latest Total Liabilities ratio of INDO US BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹97 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹43 Cr |
How is Total Liabilities of INDO US BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹97 Cr | 15.93 | |
| Mar2024 | ₹84 Cr | 21.65 | |
| Mar2023 | ₹69 Cr | 24.88 | |
| Mar2022 | ₹55 Cr | 27.04 | |
| Mar2021 | ₹43 Cr | - | |
Compare Total Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹247.7 Cr | -0.8% | -16.6% | -61.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,761.3 Cr | -3.9% | -0.5% | -14.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,970.3 Cr | -0.7% | -1.4% | 12% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,065.6 Cr | 5.6% | 10.7% | -17.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,096.1 Cr | 1.8% | -2% | -26% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹471.9 Cr | -0.8% | -6.7% | 15.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.8% |
-16.6% |
-61.1% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses